A TB skin test, or Mantoux tuberculin skin test (TST), involves a small injection of tuberculin purified protein derivative (PPD) into the forearm to check for an immune reaction.
Understanding the TB skin test offers clarity and peace of mind, especially when health screenings are part of our wellness routine. This simple procedure is a foundational tool in identifying potential exposure to tuberculosis, a bacterial infection that still impacts many lives globally. It’s a straightforward process designed to give your healthcare provider valuable insights.
Understanding Tuberculosis: A Quick Overview
Tuberculosis (TB) is a serious bacterial infection primarily affecting the lungs, though it can impact other body parts like the kidneys, spine, and brain. It spreads through the air when a person with active TB disease coughs, sneezes, or talks, releasing bacteria into their surroundings. Not everyone exposed to TB bacteria becomes sick; many develop latent TB infection.
Latent TB means the bacteria are present in the body but are inactive, causing no symptoms and not spreading to others. However, latent TB can progress to active TB disease if the immune system weakens. The Centers for Disease Control and Prevention (CDC) states that latent TB infection affects up to 13 million people in the United States. Screening tests like the TST help identify individuals with latent TB so they can receive treatment to prevent active disease.
How Is a TB Skin Test Done? — The TST Procedure Explained
The TB skin test is a precise medical procedure performed by a trained healthcare professional. It involves a specific type of injection and careful observation afterward. Knowing what to expect can ease any apprehension.
Before the Test: Preparation is Minimal
There is no special preparation required before a TB skin test. You do not need to fast or alter your diet. It is helpful to inform your healthcare provider about your medical history, including any previous TB tests, vaccinations like the BCG vaccine, or conditions that affect your immune system, as these can influence test interpretation.
The Injection: A Precise Process
During the test, a small amount of tuberculin purified protein derivative (PPD) is injected into the inner surface of your forearm. The healthcare provider cleans the injection site with an alcohol swab and allows it to air dry. They use a very small needle (typically a 27-gauge needle) and syringe to inject 0.1 mL of PPD solution just under the top layer of your skin (intradermally).
The needle is inserted with the bevel (the slanted opening) facing upwards. A successful injection creates a pale, raised bump or wheal, resembling a small mosquito bite, about 6-10 mm in diameter. This wheal indicates the PPD has been delivered correctly into the superficial layer of the skin. After the injection, the area should not be rubbed or covered with a bandage, as this could disperse the PPD and affect the test’s accuracy.
The Science Behind the Reaction: What Happens Under Your Skin
The TB skin test works by detecting a delayed-type hypersensitivity reaction. If you have been infected with TB bacteria, your immune system will have developed specific T-cells that recognize components of the bacteria. When PPD is injected, these sensitized T-cells migrate to the injection site.
Over 48 to 72 hours, these T-cells release chemicals that cause a localized inflammatory response, leading to hardening and swelling at the injection site. This hardened area, known as induration, is what the healthcare provider measures. Redness alone, without induration, does not indicate a positive reaction.
| Step | Description | Why it matters |
|---|---|---|
| Consultation | Discuss medical history, risk factors, and previous TB tests with your provider. | Helps interpret results and determine if TST is the right test. |
| Injection | 0.1 mL of PPD is injected intradermally into the inner forearm. | Precise delivery ensures the test substance interacts correctly with skin cells. |
| Waiting Period | Avoid rubbing or covering the injection site for 48-72 hours. | Allows the immune reaction to develop fully for accurate reading. |
| Reading | Return to the clinic for a healthcare professional to measure induration. | Professional measurement ensures objective and correct interpretation. |
Reading the Results: What a Positive or Negative Means
The accuracy of the TB skin test relies heavily on proper reading within the designated timeframe. This step is as important as the injection itself.
The 48-72 Hour Window: Timing is Key
You must return to your healthcare provider for the test to be read exactly 48 to 72 hours after the injection. Reading the test too early might not allow enough time for the immune reaction to develop, potentially leading to a false negative. Reading it too late can cause the reaction to fade, making accurate measurement difficult or impossible.
Measuring the Induration: Not Just Redness
A healthcare professional will examine the injection site to measure the diameter of any induration (the raised, hardened area). They use a ruler to measure the induration across the forearm, perpendicular to the long axis of the arm. It is crucial to remember that only induration is measured, not redness or bruising. Redness alone does not indicate a positive reaction.
The interpretation of the measurement depends on your individual risk factors for TB exposure and progression to active disease. For instance, an induration of 5 millimeters or more is considered positive in people with weakened immune systems, recent close contacts of individuals with active TB, or those with fibrotic changes on a chest X-ray consistent with prior TB. An induration of 10 millimeters or more is positive for recent immigrants from high-prevalence countries, injection drug users, residents and employees of high-risk settings, or children under four years old. For people with no known risk factors, an induration of 15 millimeters or more is considered positive.
| Induration (mm) | Interpretation | Relevant Risk Factors |
|---|---|---|
| ≥ 5 mm | Positive | HIV infection, recent contact with active TB, organ transplant recipients, immunosuppressed individuals. |
| ≥ 10 mm | Positive | Recent immigrants from high-prevalence countries, injection drug users, residents/employees of high-risk settings (e.g., nursing homes, prisons), children under 4. |
| ≥ 15 mm | Positive | People with no known risk factors for TB. |
| 0-4 mm | Negative | Generally indicates no TB infection, though false negatives are possible. |
Factors Influencing TST Results: Important Considerations
While the TST is a valuable screening tool, its results can sometimes be influenced by various factors, leading to either false positives or false negatives. Understanding these nuances helps in accurate interpretation.
False Positive Reactions
A false positive result means the test indicates TB infection when it is not present. The most common cause of a false positive is a previous vaccination with the Bacillus Calmette-Guérin (BCG) vaccine, which is used in some countries to prevent TB. Exposure to non-tuberculous mycobacteria, which are common in the environment and generally do not cause disease, can also trigger a positive reaction.
False Negative Reactions
Conversely, a false negative result occurs when a person has TB infection but the TST does not show a reaction. This can happen in individuals with weakened immune systems, such as those with HIV, individuals undergoing immunosuppressive therapy, or those with certain medical conditions. Very recent TB infection, where the immune system has not yet had time to react, or a very old TB infection can also lead to a false negative. Recent live-virus vaccinations or severe TB disease can also temporarily suppress the immune response, affecting the TST result.
Next Steps After a Positive TST: Further Evaluation
A positive TB skin test does not automatically mean you have active TB disease. It indicates that you have been infected with TB bacteria at some point. The next steps are crucial for determining if the infection is latent or active and for planning appropriate management.
Your healthcare provider will typically recommend further tests. This often includes a chest X-ray to check for signs of active TB disease in the lungs. If you have symptoms like a persistent cough, fever, night sweats, or unexplained weight loss, sputum samples may be collected and tested for TB bacteria. A TB blood test, known as an Interferon-Gamma Release Assay (IGRA), might also be used to confirm the infection, especially if there’s a history of BCG vaccination.
If latent TB infection is confirmed, treatment is usually recommended to prevent the infection from progressing to active TB disease. Treatment for latent TB typically involves a course of antibiotics, which can vary in duration depending on the specific regimen prescribed. The World Health Organization (WHO) consistently highlights tuberculosis as a major global health challenge, causing millions of illnesses and deaths each year, reinforcing the need for effective screening and treatment.
TB Skin Test vs. TB Blood Test: Knowing the Differences
Beyond the TST, another common method for detecting TB infection is the TB blood test, also known as an Interferon-Gamma Release Assay (IGRA). Both tests serve the same purpose but use different approaches.
The TST involves injecting PPD into the skin and measuring the reaction, requiring two visits. The IGRA, on the other hand, is a single blood test. A blood sample is taken and sent to a laboratory, where it is tested for the presence of specific immune cells that react to TB proteins. Examples of IGRAs include the QuantiFERON-TB Gold Plus and T-SPOT.TB tests.
One advantage of the IGRA is that it is not affected by prior BCG vaccination, meaning it is less likely to produce a false positive in individuals who have received the vaccine. It also requires only one visit for blood collection, which can be convenient for some individuals. However, IGRAs are generally more expensive and require specialized laboratory processing. Your healthcare provider will consider your medical history, risk factors, and logistical considerations to determine which test is most suitable for you.
How Is a TB Skin Test Done? — FAQs
Can I wash the area after the test?
Yes, you can wash the area gently with soap and water after the injection. Avoid scrubbing, rubbing, or applying any creams, lotions, or bandages to the site. Allowing the area to breathe and not irritating it helps ensure an accurate reading.
What if I miss my reading appointment?
Missing your reading appointment within the 48-72 hour window means the test results cannot be accurately interpreted. If you miss the window, you will need to have another TB skin test performed. It’s important to reschedule as soon as possible to maintain continuity in your health screening.
Does the BCG vaccine affect the TST?
Yes, previous vaccination with the BCG vaccine can cause a false positive reaction to the TB skin test. While it doesn’t always happen, it is a common reason for a positive TST in individuals from countries where BCG vaccination is routine. This is why a TB blood test might be preferred for those with a BCG history.
Is the TB skin test safe during pregnancy?
The TB skin test is generally considered safe for pregnant individuals. The amount of PPD injected is very small and does not pose a known risk to the developing fetus. Always discuss any concerns with your healthcare provider to ensure it aligns with your specific health situation.
How often should I get a TB skin test?
The frequency of TB skin testing depends on your individual risk factors and exposure history. Healthcare workers, individuals with ongoing exposure to TB, or those with certain medical conditions might require more frequent testing. Your healthcare provider will advise on the appropriate testing schedule for you.
References & Sources
- Centers for Disease Control and Prevention (CDC). “cdc.gov” The CDC provides comprehensive information and guidelines on tuberculosis prevention, diagnosis, and treatment in the United States.
- World Health Organization (WHO). “who.int” The WHO offers global health statistics, reports, and strategies concerning tuberculosis and other infectious diseases worldwide.